Skip to main navigation Skip to search Skip to main content

Orphan nuclear receptor transcription factors as drug targets

Stephen Safe, Arafat R. Oany, Wai Ning Tsui, Miok Lee, Vinod Srivastava, Srijana Upadhyay, Amanuel Hailemariam, Evan Farkas, Sarah Kakwan, Caitrina Kearns, Gargi Sivaram

Research output: Contribution to journalReview articlepeer-review

Abstract

The nuclear receptor (NR) superfamily of ligand-activated receptors plays a key role in maintaining cellular homeostasis and in pathophysiology. NRs can be subdivided into functional activities structural similarity and the existence of endogenous ligands. Most NRs are classified as those that are adopted orphan or orphan receptors which have only possible ligands or no identified endogenous ligands, respectively. In this review, the activities of the complete orphan receptor sub-family of transcription factors have been reviewed with a focus on the effects of possible endogenous (biochemicals), natural product-derived and synthetic ligands. Despite their lack of a bona-fide ligand, the orphan receptors bind structurally diverse compounds that exhibit tissue-specific agonist, antagonist and inverse agonist activities with potential for future development as clinical therapeutics for the treatment of multiple diseases.

Original languageEnglish (US)
Pages (from-to)224-260
Number of pages37
JournalTranscription
Volume16
Issue number2-3
DOIs
StatePublished - 2025

Keywords

  • Orphan nuclear receptors
  • ligands
  • transcription

ASJC Scopus subject areas

  • Biotechnology
  • Biochemistry
  • Genetics

Fingerprint

Dive into the research topics of 'Orphan nuclear receptor transcription factors as drug targets'. Together they form a unique fingerprint.

Cite this